Document is current
Any future updates will be listed below
-
Authors
Shah, Ayesha https://orcid.org/0000-0003-0710-1691
Holtmann, Gerald
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (APP1084544)
- License Information
-
More Information
Article History
Received: 22 September 2021
Accepted: 6 December 2021
First Online: 15 January 2022
Declarations
:
: GH reports to be on the advisory boards of Australian Biotherapeutics, Glutagen, and Bayer and received research support from Bayer, Abbott, Pfizer, Janssen, Takeda, and Allergan. He serves on the Boards of the West Moreton Hospital and Health Service, Queensland, UQ Healthcare, Brisbane and the Gastro-Liga, Germany. He has a patent for the Brisbane aseptic biopsy device and serves as Editor of the Gastro-Liga Newsletter. AS declare that she has no conflict of interest.
: Prof. Gerald Holtmann.
: The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/findings and content of this article.
